Correction: The costs of using unauthenticated, over-passaged cell lines: How much more data do we need? (BioTechniques 43 (575-586) DOI: 10.2144/000112598);The costs of using unauthenticated, over-passaged cell lines: How much more data do we need?

BioTechniques

Volumn 43, Issue 5, 2007, Pages 575-586

  Hughes, Peyton ^a   Marshall, Damian ^b   Reid, Yvonne ^a   Parkes, Helen ^b   Gelber, Cohava ^a  

^a ATCC   (United States)

^b LGC   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONTAMINATION; GENETIC ENGINEERING; MATHEMATICAL MODELS;

CELL LINES; CROSS-CONTAMINATION; SUBCULTURING CELLS;

CELL CULTURE;

CELL CULTURE; CELL LINE; CONTAMINATION; COST; GENETIC DRIFT; HEALTH CARE ORGANIZATION; HUMAN; MEDICAL RESEARCH; PRACTICE GUIDELINE; REVIEW;

EID: 36448955695     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/000112598     Document Type: Erratum

References (58)

1. Briske-Anderson, M.J., J.W. Finley, and S.M. Newman. 1997. Influence of culture time and passage number on morphological and physiological development of Caco-2 cells. Proc. Soc. Exp. Biol. Med. 214:248-257.
2. Chang-Liu, C.M. and G.E. Woloschak. 1997. Effect of passage number on cellular response to DNA-damaging agents: cell survival and gene expression. Cancer Lett. 113:77-86.
3. Esquenet, M., J. V. Swinnen, W. Heyns, and G. Verhoeven. 1997. LNCaP prostatic adenocarcinoma cells derived from low and high passage numbers display divergent responses not only to androgens but also to retinoids. J. Steroid Biochem. Mol. Biol. 62:391-399.
4. Langeler, E.G., C.J. van Uffelen, M.A. Blankenstein, G.J. van Steenbrugge, and E. Mulder. 1993. Effect of culture conditions on androgen sensitivity of the human prostate cancer cell line LNCaP. Prostate 25:213-223.
5. Sambuy, Y., I. De Angelis, G. Ranaldi, M.L. Scarino, A. Stammati, and F. Zucco. 2005. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol. Toxicol. 21:1-26.
6. Yu, H., T.J. Cook, and P.J. Sinko. 1997. Evidence for diminished functional expression of intestinal transporters in Caco-2 cell monolayers at high passages. Pharm. Res. 14:757-762.
7. Wenger, S.L., J.R. Senft, L.M. Sargent, R. Bamezai, N. Bairwa, and S.G. Grant. 2004. Comparison of established cell lines at different passages by karyotype and comparative genomic hybridization. Biosci. Rep. 24:631-639.
8. Mossberg, P. 2005. Wise Marketing Consultancy. Study Report: Cell Lines and Their Use in Research.
9. Behrens, I. and T. Kissel. 2003. Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers? Eur. J. Pharm. Sci. 19:433-442.
10. MacLeod, R.A., W.G. Dirks, Y.A. Reid, R.J. Hay, and H.G. Drexler. 1997. Identity of original and late passage Dami megakaryocytes with HEL erythroleukemia cells shown by combined cytogenetics and DNA fingerprinting. Leukemia 11:2032-2038.
11. Riley, S.A., G. Warhurst, P.T. Crowe, and L.A. Turnberg. 1991. Active hexose transport across cultured human Caco-2 cells: characterization and influence of culture conditions. Biochim. Biophys. Acta 1066:175-182.
12. Vierck, J.L. and M.V. Dodson. 2000. Interpretation of cell culture phenomena. Methods Cell Sci. 22:79-81.
13. Lu, S., A.W. Gough, W.F. Babrowski, and B.H. Stewart. 1996. Transport properties are not altered across Caco-2 cells with heightened TEER despite underlying physiological and ultrastructural changes. J. Pharm. Sci. 85:270-273.
14. Ranaldi, G., R. Consalvo, Y. Sambuy, and M.L. Scarino. 2003. Permeability characteristics of parental and clonal human intestinal Caco-2 cell lines differentiated in serum-supplemented and serum-free media. Toxicol. In Vitro 17:761-767.
15. Yamashita, S., T. Tanaka, Y. Endoh, Y. Taki, T. Sakane, T. Nadai, and H. Sezaki. 1997. Analysis of drug permeation across Caco-2 monolayer: implication for predicting in vivo drug absorption. Pharm. Res. 14:486-491.
16. Van Steenbrugge, G.J., C.J.C. van Uffelen, J. Bolt, and F.H. Schroder. 1991. The human prostatic cancer cell line LNCaP and its derived sublines: an in vitro model for the study of androgen sensitivity. J. Steroid Biochem. Mol. Biol. 40:207-214.
17. Gibas, Z., R. Becher, E. Kawinski, J. Horoszewicz, and A.A. Sandberg. 1984. A high-resolution study of chromosome changes in a human prostatic carcinoma cell line (LNCaP). Cancer Genet. Cytogenet. 11:399-404.
18. Draper, J.S., K. Smith, P. Gokhale, H.D. Moore, E. Maltby, J. Johnson, L. Meisner, T. Zwaka, et al. 2004. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat. Biotechnol. 22:53-54.
19. Inzunza, J., S. Sahlen, K. Holmberg, A.M. Strömberg, H. Teerijoki, B. Blennow, O. Hovatta, and H. Malmgren. 2004. Comparative genomic hybridization and karyotyping of human embryonic stem cells reveals the occurrence of an isodicentric X chromosome after long-term cultivation. Mol. Hum. Reprod. 10:461-466.
20. Mitalipova, M.M., R.R. Rao, D.M. Hoyer, R.R. Johnson, L.F. Meisner, K.L. Jones, S. Dalton, and S.L. Stice. 2005. Preserving the genetic integrity of human stem cells. Nat. Biotechnol. 23:19-20.
21. Maitra, A., D.E. Arking, N. Shivapurkar, M. Ikeda, V. Stastny, K. Kassauei, G. Sui, D.J. Cutler, et al. 2005. Genomic alterations in cultured human embryonic stem cells. Nat. Genet. 37:1099-1103.
22. Li, X.Y., Q. Jia, K.Q. Di, S.M. Gao, X.H. Wen, R.Y. Zhou, W. Wei, and L.Z. Wang. 2007. Passage number affects the pluripotency of mouse embryonic stem cells as judged by tetraploid embryo aggregation. Cell Tissue Res. 327:607-614.
23. Buehring, G.C., E.A. Eby, and M.J. Eby. 2004. Cell line cross-contamination: how aware are mammalian cell culturists of the problem and how to monitor it? In Vitro Cell. Dev. Biol. Anim. 40:211-215.
24. MacLeod, R.A.F., W.G. Dirks, Y. Matsuo, M. Kaufmann, H. Milch, and H.G. Drexler. 1999. Widespread intraspecies cross-contamination of human tumor cell lines arising at source. Int. J. Cancer 83:555-563.
25. MacLeod, R.A.F. and H.G. Drexler. 2001. Cell banks detect false cell lines: journals must act too. Lancet Oncol. 2:467-468.
26. Gey, G.O., W.D. Coffman, and M.T. Kubicek. 1952. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res. 12:264-265.
27. Culliton, B.J. 1974. HeLa cells: contamination cultures around the world. Science 184:1058-1059.
28. Drexler, H.G., W.G. Dirks, and R.A.F. MacLeod. 1999. False human hematopoietic cell lines: cross-contaminations and misinterpretations. Leukemia 13:1601-1607.
29. Drexler, H.G., W.G. Dirks, Y. Matsuo, and R.A.F. MacLeod. 2003. False leukemia-lymphoma cell lines: an update on over 500 cell lines. Leukemia 17:416-426.
30. Drexler, H.G., Y. Matsuo, and R.A.F. MacLeod. 2003. Persistent use of false myeloma cell lines. Hum. Cell 16:101-105.
31. McCulloch, E.A. and R.C. Parker. 1957. In R.W. Begg (Eds.), Canadian Cancer Conference. Vol. 2. Academic Press, New York.
32. Markovic, O. and N. Markovic. 1998. Cell cross-contamination in cell cultures: the silent and neglected danger. In Vitro Cell. Dev. Biol. Anim. 34:1-8.
33. Nelson-Rees, W.A., D.W. Daniels, and R.R. Flandermeyer. 1981. Cross-contamination of cells in culture. Science 212:446-452.
34. O'Brien, S.J. 2001. Cell culture forensics. Proc. Natl. Acad. Sci. USA 98:7656-7658.
35. Westwood, J.C., I.A. Macpherson, and D.H. Titmuss. 1957. Transformation of normal cells in tissue culture: its significance relative to malignancy and virus vaccine production. Br. J. Exp. Pathol. 38:138-154.
36. Stacey, G.N. 2000. Cell contamination leads to inaccurate data: we must take action now. Nature 403:356.
37. Masters, J.R. 2004. Human cell cross-contamination since 1983. In Vitro Cell. Dev. Biol. Anim. 40:10.
38. Gartier, S.M. 1968. Apparent HeLa cell contamination of human heteroploid cell lines. Nature 217:750-751.
39. Melcher, R., S. Maisch, S. Koehler, M. Bauer, C. Steinlein, M. Schmid, T. Kudlich, J. Schauber, et al. 2005. SKY and genetic fingerprinting reveal a cross-contamination of the putative normal colon epithelial cell line NCOL-1. Cancer Genet. Cytogenet. 151:84-87.
40. Yoshino, K., E. Iimura, K. Saijo, S. Iwase, K. Fukami, T. Ohno, Y. Obata, and Y. Nakamura. 2006. Essential role of gene profiling analysis in the authentication of human cell lines. Hum. Cell 19:43-48.
41. Liscovitch, M. and D. Ravid. 2007. A case study in misidentification of cancer cell lines: MCF/AdrR cells (re-designated NCI/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells. Cancer Lett. 245:350-352.
42. Azari, S., N. Ahmadi, M.J. Tehrani, and F. Shokri. 2007. Profiling and authentication of human cell lines using short tandem repeat (STR) loci: report from the national cell bank of Iran. Biologicals 35:195-202.
43. Chatterjee, R. 2007. Cases of mistaken identity. Science 315:928-931.
44. Hartung, T., M. Balls, C. Bardouille, O. Blanck, S. Coecke, G. Gstraunthaler, and D. Lewis. 2002. Good cell culture practice: ECVAM good cell culture practice task force report 1. Altern. Lab. Anim. 30:407-414.
45. Stacey, G.N. 1992. DNA fingerprinting transforms the art of cell authentication. Nature 357:261-262.
46. Rush, L.J., K. Heinonen, K. Mrózek, B.J. Wolf, M. Abdel-Rahman, J. Szymanska, P. Peltomäki, F. Kapadia, et al. 2002. Comprehensive cytogenetic and molecular genetic characterization of TI-1 acute myeloid leukemia cell line reveals cross-contamination with K-562 cell line. Blood 99:1874-1876.
47. Wenzel, U. and H. Daniel. 2005. Reconsidering cell line cross-contamination in NCOL-1. Cancer Genet. Cytogenet. 163:95-96.
48. Stulberg, C.S. 1973. Extrinsic cell contamination of tissue cultures, p. 1-27. In J. Fogh (Eds.), Contamination in Tissue Culture. Academic Press, New York.
49. Nelson-Rees, W.A., R.R. Flandermeyer, and P.K. Hawthorne. 1974. Banded marker chromosomes as indicators of intraspecies cellular contamination. Science 184:1093-1096.
50. Stulberg, C.S., W.D. Peterson, and W.F. Simpson. 1976. Identification of cells in culture. Am. J. Hematol. 1:237-242.
51. Nelson-Rees, W.A. and R.R. Flandermeyer. 1977. Inter- and intraspecies contamination of human breast tumor cell lines HBC and BrCa5 and other cell cultures. Science 195:1343-1344.
52. Siciliano, M.J., P.E. Barker, and R. Cailleau. 1979. Mutually exclusive genetic signatures of human breast tumor cell lines with a common chromosomal marker. Cancer Res. 39:919-922.
53. Harris, N.L., D.L. Gang, S.C. Quay, S. Poppema, P.C. Zamecnik, W.A. Nelson-Rees, and S.J. O'Brien. 1981. Contamination of Hodgkin's disease cell cultures. Nature 289:228-230.
54. Hukku, B., D. Halten, and M. Mally. 1984. Cell characterization by use of multiple genetic markers, p. 13-31. In R.T. Acton and D.J. Lynn (Eds.), Eukaryotic Cell Cultures. Plenum Press, New York.
55. Matsuba, I., A. Lernmark, and O. Madsen, B. Michelsen, J.H. Nielsen, J. Scholler, H. Vissing, B. Welinder, et al. 1988. Gene probes to detect cross-culture contamination in hormone producing cell lines. In Vitro Cell. Dev. Biol. 24:1971-1976.
56. Gignac, S.M., K. Steube, and L. Schleithoff. 1993. Multiparameter approach in the identification of cross-contaminated leukemia cell lines. Leuk. Lymphoma 10:359-368.
57. Reid, Y.A., K. O'Neill, and T.R. Chen. 1995. Cell cross-contamination of U-937. J. Leukoc. Biol. 57:804.
58. Brown, J., S.J. Reading, S. Jones, C.J. Fitchett, J. Howl, A. Martin, C.L. Longland, F. Michelangeli, et al. 2000. Critical evaluation of ECV304 as a human endothelial cell model defined by genetic analysis and functional responses: a comparison with the human bladder cancer derived epithelial cell line T24/83. Lab. Invest. 80:37-45.